Respiratory disease and high altitude

High Altitude Medicine and Biology

Volumn 5, Issue 4, 2004, Pages 435-444

  Cogo, Annalisa ^a   Fischer, Rainald ^b   Schoene, Robert ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Altitude; Asthma; Bronchial hyperresponsiveness; COPD; Trekking

Indexed keywords

ADENOSINE PHOSPHATE; ALLERGEN; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; HYDROCORTISONE; INTERLEUKIN 1; METHACHOLINE; OXYGEN; OXYHEMOGLOBIN; SHORT ACTING DRUG; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ALTITUDE; ARTERIAL OXYGEN SATURATION; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG MEGADOSE; EMPHYSEMA; ENVIRONMENTAL EXPOSURE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; GAS EXCHANGE; HORMONE RELEASE; HUMAN; HYPOXEMIA; HYPOXIA; KYPHOSCOLIOSIS; LIFESTYLE; LUNG EMBOLISM; MAST CELL DEGRANULATION; MOUNTAINEERING; NEUROMUSCULAR DISEASE; OXYGEN DISSOCIATION CURVE; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROVOCATION TEST; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SEA LEVEL; ALTITUDE DISEASE; BRONCHITIS; LUNG DISEASE; LUNG FIBROSIS; PULMONARY VALVE INSUFFICIENCY;

ALTITUDE SICKNESS; ASTHMA; BRONCHITIS; EMPHYSEMA; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; LUNG DISEASES, OBSTRUCTIVE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM; PULMONARY FIBROSIS; PULMONARY VALVE INSUFFICIENCY;

EID: 14644391583     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2004.5.435     Document Type: Review

References (61)

1. Allegra L., Cogo A., Legnani D., Diano P.L., Fasano V., and Negretto G.G. (1995). High altitude exposure reduces bronchial responsiveness to hypoosmolar aerosol in lowland asthmatics. Eur. Respir. J. 8:1842-1846.
2. Andrew M., O'Brodovich H., and Sutton J. (1987). Operation Everest II: coagulation system during prolonged decompression to 282 torr. J. Appl. Physiol. 63: 1262-1267.
3. Boner A.L., Peroni D.G., Piacentini G.L., and Venge P. (1993). Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin. Exp. Allergy 23:1021-1026.
4. Boulet L.P., and Turcotte H. (1991). Influence of water content of inspired air during and after exercise on induced bronchoconstriction. Eur. Respir. J. 4:979-984.
5. Bradley S., Solin P., Wilson J., Johns D., Walters E.H., and Naughton M.T. (1999). Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis. Chest 116:647-654.
6. BTS (British Thoracic Society). (2002). Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 57:289-304.
7. Bush A., and Geddes D. Cystic fibrosis in adolescence (2002). In: Growing up with Lung Disease: The Lung in Transition to Adult Life. A. Bush, K.-H. Carlsen, and M.S. Zach, eds. Eur. Respir. Mon. Vol. 7, No. 19; pp. 225-253.
8. Charpin D., Birnbaum J., Haddi H., Genard G., Lanteaume A., Toumi M., Farai F., van der Brembt X., and Vervolet D. (1991). Altitude and allergy to house dust mite. Am. Rev. Respir. Dis. 143:983-986.
9. Charpin D., Kleisbauer J.P., Lanteaume A., Razzouk H., Vervloet D., Toumi M., Faraj F., and Charpin J. (1988). Asthma and allergy to house-dust mites in populations living in high altitudes. Chest 93(4):758-761.
10. Chi-Lem G., and Perez-Padilla R. (1998). Gas exchange at rest during simulated altitude in patients with chronic lung disease. Arch. Med. Res. 29(1):57-62.
11. Christensen C.C., Ryg M., Refvem O.K., and Skjonsberg O.H. (2000). Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. Eur. Respir. J. 15(4): 635-639.
12. Cogo A., Basnyat B., Legnani D., and Allegra L. (1997). Bronchial asthma and airway hyperresponsiveness. Respiration 64:444-449.
13. Cunningham W.L., Becker E.J., and Krenzer F. (1965). Catecholamine in plasma and urine at high altitude. J. Appl. Physiol. 20: 607-610.
14. Dagg K.D., Thomson L.J., Clayton R.A., Ramsay S.G., and Thomson N.C. (1997). Effect of acute alterations in inspired oxygen tension on methacholine induced bronchoconstriction in patients with asthma. Thorax 52(5):453-457.
15. Dahl B., and Fassl B. (2002). Cystic fibrosis at extreme altitude: case report and review. In: Health and Height. Proceedings of the 5th World Congress on Mountain Medicine and High Altitude Physiology, Barcelona; pp. 85-88.
16. Denjean A., Roux C., Herve P., Bonniot J.P., Comoy E., Duroux P., and Gaultier C. (1988). Mild isocapnic hypoxia enhances the bronchial response to methacholine in asthmatic subjects. Am. Rev. Respir. Dis. 138: 789-793.
17. Dillard T.A., Moores L.K., Bilello K.L., and Phillips Y.Y. (1995). The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. Chest 107(2):352-357.
18. Dillard T.A., Rajagopal K.R., Slivka W.A., Berg B.W., Mehm W.J., and Lawless N.P. (1998). Lung function during moderate hypobaric hypoxia in normal subjects and patients with chronic obstructive pulmonary disease. Aviat. Space Environ. Med. 69(10):979-985.
19. Dillard T.A., Rosenberg A.P., and Berg B.W. (1993). Hypoxemia during altitude exposure. A meta-analysis of chronic obstructive pulmonary disease. Chest 103 (2):422-425.
20. Domej W., Schwaberger G., Tilz G.P., Foldes-Papp Z., Demel U., Lang J., and von Duvillard S.P. (2002). Prolonged endurance challenge at moderate altitude: effect on serum eosinophil cationic protein, eosinophil dynamics, and lung function. Chest 121(4):1111-1116.
21. Dosman J.A., Hodgson W.C., and Cockcroft D.W. (1991). Effect of cold air on the bronchial response to inhaled histamine in patients with asthma. Am. Rev. Respir. Dis. 144:45-50.
22. Fischer R. (2002). Respiratory pathologies in the mountain - how high can people go? In: Health and Height. Proceedings of the 5th World Congress on Mountain Medicine and High Altitude Physiology, Barcelona, pp. 75-79.
23. Freezer N.J., Croasdell H., Doull I.J.M., and Holgate S.T. (1995). Effect of regular inhaled beclomethsone on exercise and methacholine airway response in school children with recurrent wheeze. Eur. Respir. J. 8:1488-1493.
24. GINA (Global Initiative for Asthma) www.ginasthma.com.
25. Golan Y., Onn A., Villa Y., Avidor Y., Kivity S., Berger S.A., Shapira I., Levo Y., and Giladi M. (2002). Asthma in adventure travellers: a prospective study evaluating the occurrence and risk factors for acute exacerbations. Arch. Intern. Med. 162(21):2421-2426.
26. GOLD: Global Initiative for Chronic Obstructive Lung Disease. National Institutes of Health. National Heart, Lung, and Blood Institute. (2001). Publication Number 2701.
27. Gourgoulianis K.I., Brelas N., Hatziparasides G., Papayianni M., and Molyvdas P.A. (2001). The influence of altitude in bronchial asthma. Arch. Med. Res. 32(5):429-431.
28. Graham W.G., and Houston C.S. (1978). Short-term adaptation to moderate altitude. Patients with chronic obstructive pulmonary disease. JAMA 240(14):1491-1494.
29. Grootendorst D.C., Dhalen S.E., Van Den Bos J.W, Duiverman E.J., Veselic-Charvat M., Vrijlandt E.J.L.E., Sullivan S.O., Kumlin M., Sterk P., and Roldaan A.C. (2001). Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin. Exper. Allergy 31:400-408.
30. Guidelines for methacholine and exercise challenge testing. (2000). Am. J. Respir. Crit. Care Med. 161:309-329.
31. Hackett P.H., Creagh C.E., Grover R.F., Honigman B., Houston C.S., Reeves J.T., Sophocles A.M., and Van Hardenbroek M. (1980). High-altitude pulmonary oedema in persons without the right pulmonary artery. N. Engl. J. Med. 302(19):1070-1073.
32. Haid M.M., Paladini P., Maccherini M., Di Bisceglie M., Biagi G., and Gotti G. (1992). Air transport and the fate of pneumothorax in pleural adhesions. Thorax 47(10):833-834.
33. Hempel S.L., Monick M.M., and Hunninghake G.W. (1996). Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. (2):170-176.
34. Juniper E.F., Kline P.A., Vanzieleghem M.A., Ramsdale E.H., O'Byrne P.M., and Hargreave F.E. (1990). Effect of long term treatment with an inhaled corticosteroid on airway hyperresponsiveness and clinical asthma in non steroid-dependent asthmatics. Am. Rev. Respir. Dis. 142:822-836.
35. Kamin W.E., Fleck B., and Rose D. (2000). Intensified physiotherapy improves fitness to fly in cystic fibrosis patients. Eur. J. Med. Res. 5:402-404.
36. Karrer W., Schmid T., Wuthrich O., Baldi W., Gall E., and Portmann H.R. (1990). [Respiration of patients with chronic lung disease at 500 and 1500 meter above sea level]. Schweiz. Med. Wochenschr. 120(43):1584-1589.
37. Knox A.J., Campos-Gongora H., Wisniewski A., MacDonald I.A., and Tattersfield A.E. (1992). Modification of bronchial reactivity by physiological concentrations of plasma epinephrine. J. Appl. Physiol. (3):1004-1007.
38. Lin W.S., Shamoo D.A., Anderson K.R., Whynot J.D., Avol E.L., and Hackney J.D. (1985). Effects of heat and humidity on the response of exercising asthmatic to sulphur dioxide exposure. Am. Rev. Respir. Dis. 131:221-225.
39. Matthys H., Volz H., Erst H., Konietzko N., and Kleeberg H.R. (1974). Cardiopulmonary loading of aircraft passengers with obstructive ventilatory diseases. Schweiz. Med. Wochenschr. 104:1786-1789.
40. Mehem W.J., Dillard T.A., Berg B.W., Dooley J.W., and Rajagopal K.R. (1991). Accuracy of oxyhemoglobin saturation monitors during simulated altitude exposure of men with chronic obstructive pulmonary disease. Aviat. Space Environ. Med. 62(5):418-421.
41. Mirrakhlmov M., Brimkulov N., Cieslicki J., Tobiasz M., Kudaiberdiev Z., Moldotashev I., Shmidt G., and Zielinski J. (1993). Effects of acetazolamide on overnight oxygenation and acute mountain sickness in patients with asthma. Eur. Respir. J. (4):536-540.
42. Naeije R., De Backer D., Vachiery J.L., and De Vuyst P. (1996). High-altitude pulmonary oedema with primary pulmonary hypertension. Chest 110:286-289.
43. Naughton M.T., Rochford P.D., Pretto J.J., Pierce R.J., Niall F.C., and Irving L.B. (1995). Is normobaric simulation of hypobaric hypoxia accurate in chronic airflow limitation? Am. J. Respir. Crit. Care Med. 152:1956-1960.
44. Noviski N., Bar-Yishay E., Gur I., and Godfrey S. (1987). Exercise intensity determines and climatic conditions modify the severity of exercise-induced asthma. Am. Rev. Respir. Dis. 136:592-594.
45. Oades P.J., Buchdahl R.M., and Bush A. (2000). Prediction of hypoxaemia at high altitude in children with cystic fibrosis Eur. J. Med. Res. 5(1):9-12.
46. Peacock A.J. (1998). Asthma at altitude: the effect on asthma of the mountain environment and precautions for the traveller. Asthma J. September, 117-119.
47. Peroni D., Boner A., Vallone G., Antolini I., and Warner J. (1994). Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 149:1442-1446.
48. Piacentini G.L., Vicentini L., Mazzi P., Chilosi M., Martinati L., and Boner A.L. (1998). Mite-antigen avoidance can reduce bronchial epithelial shedding in allergic asthmatic children. Clin. Exp. Allergy 28(5):561-567.
49. Rose D.M., Fleck B., Thews O., and Kamin W.E. (2000). Blood gas-analyses in patients with cystic fibrosis to estimate hypoxemia during exposure to high altitudes in a hypobaric-chamber. Eur. J. Med. Res. 5(1):9-12.
50. Rundell K.W., and Jenkinson D.M. (2002). Exercise-induced bronchospasm in the elite athlete. Sports Med. 32(9):583-600.
51. Sawhney R.C., Malhotra A.S., and Singh T. (1991). Glucoregulatory hormones in man at high altitude. Eur. J. Appl. Physiol. 62:286-291.
52. Schoene R.B. (1999). Lung disease at high altitude. In: Hypoxia into the next millennium. R.R. Roach, P.D. Wagner, and P.H. Hackett, eds. Advances in Experimental Medicine and Biology, Vol. 474, Kluwer Academic, New York; pp. 47-56.
53. Speechly-Dick M.E., Rimmer S.J., and Hodson M.E. (1992). Exacerbations of cystic fibrosis after holidays at high altitude - a cautionary tale. Respir. Med. 86:55-56.
54. Steiner D.R., Gonzalez N.C., and Wood J.G. (2003). Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J. Appl. Physiol. 94(1):325-334.
55. Tam E.K., Geoffrey A., Myers D.J., Seltzer J., Sheppard D., and Boushey H.A. (1985). Effect of eucapnic hypoxia on bronchomotor tone and on the bronchomotor response to dry air in asthmatic subjects. Am. Rev. Respir. Dis. 132:690-693.
56. Townend M. (1996). Asthma in mountaineers. Respir. Dis. Pract. Autumn, 21-23.
57. Van Velzen E., van den Bos J.W., Benckhuijsen J.A., van Essel T., de Bruijin R., and Aalbers R. (1996). Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 51:582-584.
58. Vargas M.H., Sienra-Monge J.J., Diaz-Mejia G., and DeLeon-Gonzalez M. (1999). Asthma and geographical altitude: an inverse relationship in Mexico. J. Asthma (6):511-517.
59. Wallace T.W., Wong T., O'Bichere A., and Ellis B.W. (1995). Managing in flight emergencies. BMJ 311(7001):374-376.
60. Wardlaw A.J. (1993). The role of air pollution in asthma. Clin. Exp. Allergy 23:81-96.
61. Woolcock A.J., Keena V., and Peat J.K. (2001). Definition, classification, epidemiology and risk factors. In: Manual of Asthma Management, P. O'Byrne and N.C. Thomson, eds. W.B. Saunders, London; pp. 3-18.